Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Oncolytic and local immunotherapy

Original research

Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis

Online download statistics by month:

Online download statistics by month: March 2022 to August 2023

	Abstract	Full	Pdf
Mar 2022	420	429	283
Apr 2022	196	200	188
May 2022	159	162	100
Jun 2022	149	153	58
Jul 2022	139	141	44
Aug 2022	182	183	30
Sep 2022	238	244	90
Oct 2022	249	256	64
Nov 2022	133	134	47
Dec 2022	97	97	32
Jan 2023	106	106	44
Feb 2023	99	99	43
Mar 2023	69	71	45
Apr 2023	42	42	30
May 2023	73	73	28
Jun 2023	80	80	22
Jul 2023	49	49	36
Aug 2023	58	58	22
Total	2538	2577	1206